Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973403979> ?p ?o ?g. }
- W1973403979 endingPage "296" @default.
- W1973403979 startingPage "290" @default.
- W1973403979 abstract "<h3>Objective</h3> The combination of pegylated interferon (PEG-IFN), ribavirin (RBV) and a protease inhibitor (PI) has been approved in summer 2011 for the treatment of genotype 1 (G1) hepatitis C virus (HCV)-infected patients, with a substantially improved efficacy. The aim of this study was to estimate the number of G1 patients to be treated in France in 2012 and associated costs. <h3>Methods</h3> A published model of HCV and data on PEG-IFN sales were used to estimate patients needing treatment using three scenarios. (1) HCV screening rate unchanged versus 2010; proportion of treated F0–F1 patients unchanged, proportion of treated F2–F4 patients increased to the current proportion of treated F2–F4 G2/3 patients. (2) Scenario 1 but the proportion of treated F0–F1 patients increased to the current proportion of treated F0–F1 G2/3 patients. (3) Scenario 2 but a 5% increase in the HCV screening rate. To estimate cost, treatment duration was multiplied by drug unit cost. Probabilities corresponding to treatment duration were estimated based on liver fibrosis stage, treatment-naive or experienced status of the patient and virological response kinetics on treatment. <h3>Results</h3> Compared with the 5100 G1 patients treated in 2010, the number of G1 patients receiving treatment in 2012 would be 15 000 in scenario 1, 18 300 in scenario 2 and 19 400 in scenario 3, among whom 2.5–3.7% may receive PEG-IFN/RBV and 96.3–97.5% PEG-IFN/RBV+PI. Costs associated with this regimen use ranged from 497 to 638 million Euros. <h3>Conclusion</h3> These model-based estimates indicate that new anti-HCV treatments may result in a three- to fourfold increase in the number of G1 patients to be treated in France in 2012." @default.
- W1973403979 created "2016-06-24" @default.
- W1973403979 creator A5017832857 @default.
- W1973403979 creator A5023875775 @default.
- W1973403979 creator A5049579355 @default.
- W1973403979 creator A5061346300 @default.
- W1973403979 creator A5064601780 @default.
- W1973403979 creator A5067483186 @default.
- W1973403979 creator A5072596897 @default.
- W1973403979 creator A5076282431 @default.
- W1973403979 date "2011-09-19" @default.
- W1973403979 modified "2023-10-15" @default.
- W1973403979 title "Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis" @default.
- W1973403979 cites W1497131577 @default.
- W1973403979 cites W1818838497 @default.
- W1973403979 cites W1964051982 @default.
- W1973403979 cites W1974753566 @default.
- W1973403979 cites W1975964768 @default.
- W1973403979 cites W1979174109 @default.
- W1973403979 cites W1987798475 @default.
- W1973403979 cites W1997216546 @default.
- W1973403979 cites W2001973858 @default.
- W1973403979 cites W2020856620 @default.
- W1973403979 cites W2040820236 @default.
- W1973403979 cites W2045315462 @default.
- W1973403979 cites W2046658390 @default.
- W1973403979 cites W2057603763 @default.
- W1973403979 cites W2058128629 @default.
- W1973403979 cites W2059087834 @default.
- W1973403979 cites W2061108146 @default.
- W1973403979 cites W2061639757 @default.
- W1973403979 cites W2063740102 @default.
- W1973403979 cites W2064546869 @default.
- W1973403979 cites W2067273401 @default.
- W1973403979 cites W2079103647 @default.
- W1973403979 cites W2085806058 @default.
- W1973403979 cites W2100797437 @default.
- W1973403979 cites W2119764771 @default.
- W1973403979 cites W2125963799 @default.
- W1973403979 cites W2126503705 @default.
- W1973403979 cites W2132290252 @default.
- W1973403979 cites W2143559032 @default.
- W1973403979 cites W2168229737 @default.
- W1973403979 cites W2316282668 @default.
- W1973403979 cites W259575300 @default.
- W1973403979 doi "https://doi.org/10.1136/gutjnl-2011-300586" @default.
- W1973403979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21930731" @default.
- W1973403979 hasPublicationYear "2011" @default.
- W1973403979 type Work @default.
- W1973403979 sameAs 1973403979 @default.
- W1973403979 citedByCount "18" @default.
- W1973403979 countsByYear W19734039792012 @default.
- W1973403979 countsByYear W19734039792013 @default.
- W1973403979 countsByYear W19734039792014 @default.
- W1973403979 countsByYear W19734039792015 @default.
- W1973403979 countsByYear W19734039792016 @default.
- W1973403979 countsByYear W19734039792017 @default.
- W1973403979 countsByYear W19734039792018 @default.
- W1973403979 crossrefType "journal-article" @default.
- W1973403979 hasAuthorship W1973403979A5017832857 @default.
- W1973403979 hasAuthorship W1973403979A5023875775 @default.
- W1973403979 hasAuthorship W1973403979A5049579355 @default.
- W1973403979 hasAuthorship W1973403979A5061346300 @default.
- W1973403979 hasAuthorship W1973403979A5064601780 @default.
- W1973403979 hasAuthorship W1973403979A5067483186 @default.
- W1973403979 hasAuthorship W1973403979A5072596897 @default.
- W1973403979 hasAuthorship W1973403979A5076282431 @default.
- W1973403979 hasConcept C126322002 @default.
- W1973403979 hasConcept C142462285 @default.
- W1973403979 hasConcept C203014093 @default.
- W1973403979 hasConcept C2522874641 @default.
- W1973403979 hasConcept C2776178377 @default.
- W1973403979 hasConcept C2776408679 @default.
- W1973403979 hasConcept C2776455275 @default.
- W1973403979 hasConcept C2776461080 @default.
- W1973403979 hasConcept C2778159067 @default.
- W1973403979 hasConcept C2780040827 @default.
- W1973403979 hasConcept C2781143361 @default.
- W1973403979 hasConcept C2781413609 @default.
- W1973403979 hasConcept C2909179924 @default.
- W1973403979 hasConcept C2993143319 @default.
- W1973403979 hasConcept C71924100 @default.
- W1973403979 hasConcept C90924648 @default.
- W1973403979 hasConceptScore W1973403979C126322002 @default.
- W1973403979 hasConceptScore W1973403979C142462285 @default.
- W1973403979 hasConceptScore W1973403979C203014093 @default.
- W1973403979 hasConceptScore W1973403979C2522874641 @default.
- W1973403979 hasConceptScore W1973403979C2776178377 @default.
- W1973403979 hasConceptScore W1973403979C2776408679 @default.
- W1973403979 hasConceptScore W1973403979C2776455275 @default.
- W1973403979 hasConceptScore W1973403979C2776461080 @default.
- W1973403979 hasConceptScore W1973403979C2778159067 @default.
- W1973403979 hasConceptScore W1973403979C2780040827 @default.
- W1973403979 hasConceptScore W1973403979C2781143361 @default.
- W1973403979 hasConceptScore W1973403979C2781413609 @default.
- W1973403979 hasConceptScore W1973403979C2909179924 @default.
- W1973403979 hasConceptScore W1973403979C2993143319 @default.
- W1973403979 hasConceptScore W1973403979C71924100 @default.